Literature DB >> 3336669

Adenomyosis: diagnosis with MR imaging.

K Togashi1, K Nishimura, K Itoh, I Fujisawa, S Noma, M Kanaoka, Y Nakano, H Itoh, H Ozasa, S Fujii.   

Abstract

Magnetic resonance (MR) imaging characteristics of adenomyosis were studied in eight women (aged 37-49 years) who underwent hysterectomy, and detailed radiologic/pathologic correlation was conducted in all cases. Adenomyosis produced diffuse and smooth uterine enlargement. The extent of the lesion was clearly identified on images obtained with long repetition time and long echo time; a diffuse, low-intensity area accompanied by tiny high-intensity spots was seen subjacent to the endometrium. The area appeared as a localized or diffuse thickening of the junctional zone because it was often isointense with this zone. Pathologic examination confirmed that the extent of adenomyosis correlated well with the low-intensity region on MR images and that both hemorrhagic areas and nonbleeding endometrial tissue corresponded to the high-intensity spots. The lesion consisted of distorted and compacted smooth muscle cells, but microscopic studies failed to explain the definitive difference in intensity between areas of adenomyosis and myometrium.

Entities:  

Mesh:

Year:  1988        PMID: 3336669     DOI: 10.1148/radiology.166.1.3336669

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

1.  MR imaging of the uterus and cervix in healthy women: determination of normal values.

Authors:  Elke A M Hauth; Horst J Jaeger; Hanna Libera; Silke Lange; Michael Forsting
Journal:  Eur Radiol       Date:  2006-05-16       Impact factor: 5.315

2.  The normal uterus on magnetic resonance imaging and variations associated with the hormonal state.

Authors:  J M Bartoli; G Moulin; L Delannoy; C Chagnaud; M Kasbarian
Journal:  Surg Radiol Anat       Date:  1991       Impact factor: 1.246

3.  A thickened or indistinct junctional zone on T2-weighted MR images in patients with endometrial carcinoma: pathologic consideration based on microcirculation.

Authors:  Yumiko Oishi Tanaka; Masato Nishida; Hajime Tsunoda; Yoshihito Ichikawa; Yukihisa Saida; Yuji Itai
Journal:  Eur Radiol       Date:  2003-01-25       Impact factor: 5.315

4.  Comparative analysis of changes in MR imaging of pre and post intrauterine progesterone implants in adenomyosis cases.

Authors:  S Dashottar; A K Singh; J Debnath; C G Muralidharan; R K Singh; Suman Kumar
Journal:  Med J Armed Forces India       Date:  2015-03-12

5.  Diagnosing adenomyosis with MRI: a prospective study revisiting the junctional zone thickness cutoff of 12 mm as a diagnostic marker.

Authors:  Tina Tellum; Gordana V Matic; Johann B Dormagen; Staale Nygaard; Ellen Viktil; Erik Qvigstad; Marit Lieng
Journal:  Eur Radiol       Date:  2019-07-01       Impact factor: 5.315

6.  Women seeking second opinion for symptomatic uterine leiomyoma: role of comprehensive fibroid center.

Authors:  Nelly Tan; Timothy D McClure; Christopher Tarnay; Michael T Johnson; David Sk Lu; Steven S Raman
Journal:  J Ther Ultrasound       Date:  2014-04-15

7.  Phenotypic characterization of adenomyosis occurring at the inner and outer myometrium.

Authors:  Yohei Kishi; Keiji Shimada; Tomomi Fujii; Tomoko Uchiyama; Chiharu Yoshimoto; Noboru Konishi; Chiho Ohbayashi; Hiroshi Kobayashi
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

Review 8.  Classifying Adenomyosis: Progress and Challenges.

Authors:  Marwan Habiba; Giuseppe Benagiano
Journal:  Int J Environ Res Public Health       Date:  2021-11-25       Impact factor: 3.390

9.  Norethindrone acetate in the medical management of adenomyosis.

Authors:  Ozgul Muneyyirci-Delale; Ashadeep Chandrareddy; Siddhi Mankame; Nanna Osei-Tutu; Hans von Gizycki
Journal:  Pharmaceuticals (Basel)       Date:  2012-10-22

10.  The benefit of adenomyomectomy on fertility outcomes in women with rectovaginal endometriosis with coexisting adenomyosis.

Authors:  Yohei Kishi; Maki Yabuta
Journal:  Gynecol Minim Invasive Ther       Date:  2016-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.